Therapeutic Advances for the Management of Pediatric Patients with Atopic Dermatitis

To tune into this virtual event, please visit:
https://arraylive.com/activity_files/75bb7593-0262-11eb-a1de-0a1fc221c10e/10042020_AtopicDermatitis.html

Program Overview

This virtual continuing medical education program will highlight therapeutic advances for the management of patients with atopic dermatitis, focusing primarily on the pediatric population. The expert faculty, chaired by Dr. Lawrence F. Eichenfield, will first cover the immunopathology and characteristics of disease, including best practices for severity scoring to accurately assess pediatric patients. Following, recent clinical trial data for the treatment of atopic dermatitis will be reviewed and clinical relevance debated in an interactive panel format.  The faculty will discuss optimal management strategies, including both guideline-driven and holistic approaches for improving patient outcomes and quality of life. This interactive, case-based education will update clinicians on current practices to better treat and manage pediatric patients with atopic dermatitis.

Agenda

1. Disease Characteristics, Diagnostics, Immunopathology, and Severity Scoring to Accurately Assess Pediatric Patients with Atopic Dermatitis – Bob Geng, MD
2. Clinical Trial Analysis: Therapeutic Target Mechanisms of Action for the Treatment of Atopic Dermatitis – Lawrence F. Eichenfield, MD
3. Guideline-Driven Pharmacotherapeutic Treatment Strategies and the Holistic Approach to Improve Outcomes in Pediatric Patients with Atopic Dermatitis – Wynnis Tom, MD
4. Case Presentations & Faculty Panel Discussion Question & Answers

Educational Objectives

1. Review the disease characteristics, diagnostics, immunopathology, and severity scoring to accurately assess pediatric patients with atopic dermatitis.
2. Summarize recent clinical trial data and therapeutic target mechanisms of action for the treatment of atopic dermatitis.
3. Discuss guideline-driven pharmacotherapeutic treatment strategies and the holistic approach to improve outcomes in pediatric patients with atopic dermatitis.

Chair

Lawrence F. Eichenfield, MD
Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
University of California, San Diego School of Medicine
Chief, Pediatric and Adolescent Dermatology
Rady Children’s Hospital
San Diego, California

Faculty

Bob Geng, MD
Assistant Clinical Professor, Medicine
Rady Children’s Hospital
San Diego, California

Wynnis Tom, MD
Associate Clinical Professor
Department of Pediatrics and Medicine
University of California, San Diego
Rady Children’s Hospital
San Diego, California

Joint Accreditation Standards for Commercial Support

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

AcademicCME designates this live material for a maximum of 1.50 AMA PRA Category 1 Credits^TM.

Participants should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Pfizer Inc.

CE Inquiries/Special Needs

For all CME inquiries or special needs, please contact [email protected] or 610-687-3300.

 

Provided by AcademicCME

 

This symposium is neither sponsored nor endorsed by the American Academy of Pediatrics

 

Further details regarding how to tune in to this complimentary CE program will be provided via email prior to the event.

 

Please email [email protected] with any questions or visit academiccme.com/AtopicDermCE closer to the event for updated details.

You can also follow us on Twitter @academiccme for real-time updates and information.